P. Dougherty

发表

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Paul C. Rogers, Bin Zhang, Jeffrey S. Miller, 2017, Cancer research.

A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma

S. Barsky, D. Vallera, P. Dougherty, 2013, Targeted Oncology.

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells

J. Miller, D. Vallera, M. Gleason, 2016, Targeted Oncology.

ARID5B regulates metabolic programming in human adaptive NK cells

Bin Zhang, Cheng-Ying Wu, Jeffrey S. Miller, 2018, The Journal of experimental medicine.

Adaptive NK Cells Are Expanded By NKG2C-Agonist Antibodies and Retain Their Cytotoxic and Secretory Properties

Bin Zhang, Jeffrey S. Miller, J. P. Houchins, 2018, Blood.